금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
BlackRock profits jump as assets under management hit a record $15 trillion
Shares in the fund manager rise as company says its will boost quarterly buybacks to $550 million...
Ukraine Intensifies Attacks on Russian Tankers in the Black Sea
After striking 116 vessels linked to Russia’s shadow fleet in the Sea of Azov in recent weeks, Ukrai...
Palantir Joins Software Stock Rally Amid Semiconductor, Tech Sell-Off
Palantir stock rose Friday amid a software rebound. Palantir would snap a seven-session losing streak if it closes up.
First Majestic secures construction permits for Santa Elena mine expansion
Universal sets 'Donkey' spinoff film for June 2028 theatrical release
Discounted bond funds, especially at scandal-hit Wamco, may offer an investment opportunity
Professional investment advisers wear handcuffs when they manage clients’ money — but you don’t.
Midday Need to Know: Chip stocks fall, consumer sentiment revised & more
3 Reasons to Avoid IBM and 1 Stock to Buy Instead
Over the past six months, IBM’s shares (currently trading at $258.55) have posted a disappointing 15.3% loss, well below the S&P 500’s 6.2% gain. This may have investors wondering how to approach the ...
Update: US Equity Indexes Mixed as Steepest Decliner Technology Eats into Consumer Discretionary Gains
(Updates with index/price moves, macroeconomic data, and analyst comment from the first paragraph.)
Stock market stays ‘very solid’ thanks to strong earnings amid ‘AI fatigue’ – Ed Yardeni
3 Consumer Stocks That Fall Short
Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. But they’re also double-edged swords as they often lag in booming conditions, and this pattern has ...
A new bill would cap Medicare enrollees’ annual expenses at $5,000 — and could cost the government ‘tens of billions’
The long-shot proposal would guarantee some cost protection to all people with Medicare.
Two senators seek Polymarket probe over social media campaign - report
Lilly, J&J, AbbVie hit new 52-week highs as healthcare outperforms